CDSCO approves Biocon diabetes drug Liraglutide Ruchika Sharma3 Jun 2025 11:51 AM ISTLiraglutide is a synthetic analog of GLP-1 peptide and is administered as a once-daily injection.
Biocon posts more than twofold increase in Q4 profit Ruchika Sharma9 May 2025 2:30 PM ISTBengaluru: Biocon, an Indian biopharmaceutical company, has reported a more than twofold increase in its fourth-quarter profit, driven by robust...
Biocon Biologics secures multiple market access agreements in US for Yesintek Ruchika Sharma5 May 2025 12:50 PM ISTYESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
"Who's going to pay price to bring back manufacturing in US", asks Biocon MD Ruchika Sharma15 April 2025 10:30 AM ISTNew Delhi: Siddharth Mittal, the CEO and Managing Director of Biocon Limited, raised a critical question on Friday, asking who would bear...
Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients Ruchika Sharma11 April 2025 12:30 PM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...
Biocon Biologics gets USFDA nod for cancer drug Jobevne Ruchika Sharma10 April 2025 12:39 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...
Biocon to raise up to Rs 600 crore Ruchika Sharma7 April 2025 4:15 PM ISTBangalore: In a recent BSE filing, Biocon has said that its Board of Directors has approved to raise up to Rs 600 crore in one or...
Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension Ruchika Sharma24 March 2025 11:30 AM ISTBengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval from the...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Biocon launches Liraglutide for diabetes, obesity in UK Ruchika Sharma28 Feb 2025 8:26 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for...
Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis Ruchika Sharma7 Feb 2025 11:30 AM ISTBengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...
Biocon likely to list key biosimilars business by March 2026 Ruchika Sharma1 Feb 2025 2:30 PM ISTHyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, starting in April and is likely...
